Elevated plasma resistin concentrations in patients with liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 1, 2008, Pages 73-77

  Kakizaki, Satoru ^a   Sohara, Naondo ^a   Yamazaki, Yuichi ^a   Horiguchi, Norio ^a   Kanda, Daisuke ^a   Kabeya, Kenji ^a   Katakai, Kenji ^a   Sato, Ken ^a   Takagi, Hitoshi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipocytokine; Adiponectin; Homeostatic model assessment insulin resistance (HOMA IR); Liver cirrhosis; Quantitative insulin sensitivity check index (QUICKI); Resistin

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; RESISTIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 37249047988     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04757.x     Document Type: Article

References (23)

1. Steppan CM, Brown EJ, Wright CM et al. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA 2001 98 : 502 6.
2. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001 409 : 307 12.
3. Shojima N, Sakoda H, Ogihara T et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002 51 : 1737 44.
4. Moore GB, Chapman H, Holder JC et al. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem. Biophys. Res. Commun. 2001 286 : 735 41.
5. Way JM, Gorgun CZ, Tong Q et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator- activated receptor gamma agonists. J. Biol. Chem. 2001 276 : 25651 3.
6. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 2001 285 : 561 4.
7. Juan CC, Au LC, Fang VS et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem. Biophys. Res. Commun. 2001 289 : 1328 33.
8. Azuma K, Katsukawa F, Oguchi S et al. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 2003 11 : 997 1001.
9. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 2003 88 : 5452 5.
10. Youn BS, Yu KY, Park HJ, Lee NS et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2004 89 : 150 6.
11. Heilbronn LK, Rood J, Janderova L et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 2004 89 : 1844 8.
12. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994 19 : 616 27.
13. Petrides AS, Stanley T, Matthews DE, Vogt C, Bush AJ, Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 1998 28 : 141 9.
14. Sohara N, Takagi H, Kakizaki S, Sato K, Mori M. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels. Liver Int. 2005 25 : 28 32.
15. Shimizu H, Kakizaki S, Tsuchiya T et al. An increase of circulating leptin in patients with liver cirrhosis. Int. J. Obes. Relat. Metab. Disord. 1998 22 : 1234 8.
16. Tietge UJ, Boker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am. J. Physiol. Endocrinol. Metab. 2004 287 : E82 9.
17. Tacke F, Wustefeld T, Horn R et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J. Hepatol. 2005 42 : 666 73.
18. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 2000 85 : 2402 10.
19. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones, leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 2002 13 : 51 9.
20. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005 174 : 5789 95.
21. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 111 : 932 9.
22. Koike K. Hepatitis C virus infection can present with metabolic disease by inducing insulin resistance. Intervirology 2006 49 : 51 7.
23. Liu CJ, Chen PJ, Jeng YM et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J. Hepatol. 2005 43 : 235 42.